Sponsor
M.D. Anderson Cancer Center
Status
Active, not recruiting
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT01893307
This randomized phase II/III trial studies the side effects and how well intensity-modulated proton beam therapy works and compares it to intensity-modulated photon therapy in treating patients with stage III-IVB oropharyngeal cancer. Radiation therapy uses high-energy x-rays, protons, and other types of radiation to kill tumor cells and shrink tumors. It is not yet known whether intensity-modulated proton beam therapy is more effective than intensity-modulated photon therapy in treating oropharyngeal cancer.
Intervention
Intensity-Modulated Radiation Therapy, Laboratory Biomarker Analysis, Photon Beam Radiation Therapy, Proton Beam Radiation Therapy, Quality-of-Life Assessment
Condition
Stage III Oropharyngeal Squamous Cell Carcinoma AJCC V7, Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC V7, Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC V7
Investigators
Steven J Frank